ArticleNeuropsychiatric disease and treatment2019

Melatonin receptor agonists-ramelteon and melatonin-for bipolar disorder: a systematic review and meta-analysis of double-blind, randomized, placebo-controlled trials.

Taro Kishi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.